MAPK8 and neoplasm: In an animal model of orthotopic xenografts, tumors were treated successfully with very low doses of JNKi/TRAIL combination therapy, showing >70% reduction in tumor weight compared to JNK (11%) or TRAIL (10%) alone, suggesting a synergistic rather than an additive effect (Figure 7 and Supplementary Table S1).